INT265927

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 4
Disease Relevance 2.68
Pain Relevance 0.31

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
body 1
Clas4 (Mus musculus)
Pain Link Frequency Relevance Heat
Inflammation 32 67.24 Quite High
Pain 4 65.52 Quite High
rheumatoid arthritis 60 54.76 Quite High
cINOD 8 29.44 Quite Low
agonist 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Body Weight 12 99.28 Very High Very High Very High
Disorder Of Lipid Metabolism 92 98.40 Very High Very High Very High
Cardiovascular Disease 40 96.68 Very High Very High Very High
Hyperlipidemia 8 87.84 High High
Coronary Artery Disease 8 86.56 High High
Myocardial Infarction 8 85.00 Quite High
Nicotine Addiction 8 83.48 Quite High
Obesity 48 77.36 Quite High
INFLAMMATION 36 67.24 Quite High
Arthralgia 4 65.92 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In our study, CLAs supplementation had no effect on body weight.
CLAs Binding (supplementation) of in body associated with body weight
1) Confidence 0.02 Published 2008 Journal Vascular Health and Risk Management Section Body Doc Link PMC2663461 Disease Relevance 0.27 Pain Relevance 0
The patients were divided into four groups to receive randomly either CLAs (group C), vitamin E (group E), both CLAs and vitamin E (group CE) or placebo (group P).
CLAs Binding (receive) of
2) Confidence 0.02 Published 2008 Journal Vascular Health and Risk Management Section Body Doc Link PMC2663461 Disease Relevance 0.85 Pain Relevance 0.15
The patients were divided into four groups to receive randomly either CLAs (group C), vitamin E (group E), both CLAs and vitamin E (group CE) or placebo (group P).
CLAs Binding (receive) of
3) Confidence 0.02 Published 2008 Journal Vascular Health and Risk Management Section Body Doc Link PMC2663461 Disease Relevance 0.85 Pain Relevance 0.15
Our data show that supplementation of vitamin E and its combination with CLAs for at least three months can increase HDL-C nonsignificantly by 3.4% and 4.5%, respectively.
CLAs Binding (combination) of associated with disorder of lipid metabolism
4) Confidence 0.02 Published 2008 Journal Vascular Health and Risk Management Section Body Doc Link PMC2663461 Disease Relevance 0.71 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox